Showing results (151-160 of 660) with videos related to
Sort By:
Pageof 66
Nature Cancer|March 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study resultsRashmi K Murthy, Barbara J O'Brien, Donald A Berry, et al.Nature Cancer|April 24, 2026
Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironmentJoshua D Bernstock, Lennard Spanehl, E Antonio ChioccaNature Cancer|April 3, 2026
Leptomeningeal metastatic cancer cells induce a permissive choroid plexus vasculature through extracellular-vesicle-derived 5-HIAA signalingYang Huang, Yifan Hou, Jiahui Yang, et al.Nature Cancer|April 16, 2026
Advances in predicting T cell epitope recognition for cancer immunotherapyDavid Gfeller, Julien Racle, Alexandre Harari, et al.Nature Cancer|August 12, 2026
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemiaQiwei Wang, Jingyi Li, Xin Zeng, et al.Nature Cancer|August 19, 2026
A lactate-α-ketoglutarate metabolic circuit in tumor-infiltrating regulatory T cells accelerates tumor progression by inducing NK cell senescenceTiezhu Shi, Yufeng Ding, Ying Chen, et al.Nature Cancer|August 21, 2026
Rewiring immunity with in vivo CAR T cell engineeringClare Y Slaney, Rachel Xu, Shiyi Wu, et al.Nature Cancer|August 26, 2026
Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cellsLizhi Pang, Yang Liu, Fei Zhou, et al.Nature Cancer|September 22, 2026
An iron-regulated methionine redox axis governs adipose browning and cancer cachexiaJung Seung Nam, Sung Shin Ahn, Yeonoh Shin, et al.Nature Cancer|September 25, 2026
Stroke drives glioma progression through the emergence of tumor-associated astrocytes with reduced Ca2+ activityQi Ye, Christine Madamba, Junsung Woo, et al.Pageof 66